These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3311208)

  • 1. Interleukin-2 production and response to interleukin-2 by peripheral blood mononuclear cells from patients after bone marrow transplantation: II. Patients receiving soybean lectin-separated and T cell-depleted bone marrow.
    Welte K; Keever CA; Levick J; Bonilla MA; Merluzzi VJ; Mertelsmann R; Evans R; O'Reilly RJ
    Blood; 1987 Nov; 70(5):1595-603. PubMed ID: 3311208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 2-activated killer cells in patients following transplants of soybean lectin-separated and E rosette-depleted bone marrow.
    Keever CA; Welte K; Small T; Levick J; Sullivan M; Hauch M; Evans RL; O'Reilly RJ
    Blood; 1987 Dec; 70(6):1893-903. PubMed ID: 3118990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reconstitution of T-cell function after CD6-depleted allogeneic bone marrow transplantation.
    Soiffer RJ; Bosserman L; Murray C; Cochran K; Daley J; Ritz J
    Blood; 1990 May; 75(10):2076-84. PubMed ID: 1970938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired T and NK cell response of bone marrow and peripheral blood stem cell products to interleukin (IL)-2.
    Ozerol I; Ageitos A; Heimann DG; Talmadge JE
    Int J Immunopharmacol; 1999 Aug; 21(8):509-21. PubMed ID: 10458540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of low-dose interleukin-2 on disease relapse after T-cell-depleted allogeneic bone marrow transplantation.
    Soiffer RJ; Murray C; Gonin R; Ritz J
    Blood; 1994 Aug; 84(3):964-71. PubMed ID: 8043878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective interleukin 2 production in patients after bone marrow transplantation and in vitro restoration of defective T lymphocyte proliferation by highly purified interleukin 2.
    Welte K; Ciobanu N; Moore MA; Gulati S; O'Reilly RJ; Mertelsmann R
    Blood; 1984 Aug; 64(2):380-5. PubMed ID: 6378275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and immunologic effects of prolonged infusion of low-dose recombinant interleukin-2 after autologous and T-cell-depleted allogeneic bone marrow transplantation.
    Soiffer RJ; Murray C; Cochran K; Cameron C; Wang E; Schow PW; Daley JF; Ritz J
    Blood; 1992 Jan; 79(2):517-26. PubMed ID: 1730094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 production following T-cell-depleted and unmodified marrow grafts.
    Sahdev I; O'Reilly R; Black P; Heller G; Hoffmann M
    Pediatr Hematol Oncol; 1996; 13(1):55-67. PubMed ID: 8718503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
    Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
    J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferation and cytolytic function of anti-CD3 + interleukin-2 stimulated peripheral blood mononuclear cells following bone marrow transplantation.
    Katsanis E; Anderson PM; Filipovich AH; Hasz DE; Rich ML; Loeffler CM; Ochoa AC; Weisdorf DJ
    Blood; 1991 Sep; 78(5):1286-91. PubMed ID: 1831682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tetanus toxoid antibody production after mismatched T cell-depleted bone marrow transplantation.
    Benkerrou M; Wara DW; Elder M; Dror Y; Merino A; Colombe BW; Garovoy M; Cowan MJ
    J Clin Immunol; 1994 Mar; 14(2):98-106. PubMed ID: 8195318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between the increase of circulating CD3+ CD57+ lymphocytes and T cell dysfunction in recipients of bone marrow transplantation.
    Izquierdo M; Balboa MA; Fernández-Rañada JM; Figuera A; Torres A; Iriondo A; López-Botet M
    Clin Exp Immunol; 1990 Oct; 82(1):145-50. PubMed ID: 1698579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of circulating suppressor T lymphocytes in bone marrow transplant recipients.
    Gebel HM; Kaizer H; Landay AL
    Transplantation; 1987 Feb; 43(2):258-63. PubMed ID: 2949405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction by interleukin-7 of lymphokine-activated killer activity in lymphocytes from autologous and syngeneic marrow transplant recipients before and after systemic interleukin-2 therapy.
    Pavletic Z; Benyunes MC; Thompson JA; Lindgren CG; Massumoto C; Alderson MR; Buckner CD; Fefer A
    Exp Hematol; 1993 Sep; 21(10):1371-8. PubMed ID: 8359237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soybean agglutinin-positive natural suppressor cells in mouse bone marrow inhibit interleukin 2 production and utilization in mixed lymphocyte reactions.
    Hoskin DW; Bowser DA; Brooks-Kaiser JC
    J Leukoc Biol; 1992 Jun; 51(6):649-56. PubMed ID: 1535357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts.
    Keever CA; Small TN; Flomenberg N; Heller G; Pekle K; Black P; Pecora A; Gillio A; Kernan NA; O'Reilly RJ
    Blood; 1989 Apr; 73(5):1340-50. PubMed ID: 2649174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary characterization of functional residual host-type T lymphocytes following conditioning for allogeneic HLA-matched bone marrow transplantation (BMT).
    Kedar E; Or R; Naparstek E; Zeira E; Slavin S
    Bone Marrow Transplant; 1988 Mar; 3(2):129-40. PubMed ID: 3048477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphokine production by T-cell clones after human bone marrow transplantation.
    Velardi A; Varese P; Terenzi A; Dembech C; Albi N; Grossi CE; Moretta L; Martelli MF; Grignani F; Mingari MC
    Blood; 1989 Oct; 74(5):1665-72. PubMed ID: 2506949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 2 induces interferon alpha/beta production in mouse bone marrow cells.
    Reyes VE; Ballas ZK; Singh H; Klimpel GR
    Cell Immunol; 1986 Oct; 102(2):374-85. PubMed ID: 3100059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two immuno-mechanical methods of T-cell depletion of human bone-marrow for prevention of graft-versus-host disease: soybean lectin agglutination and sheep erythrocyte rosette depletion versus triple rosette depletion.
    Woolfrey AE; Neudorf S; Filipovich AH
    Thymus; 1985; 7(6):327-34. PubMed ID: 3909540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.